Click for best price
Cell Gene Therapy Drug Delivery Devices Market Size, Share 2023
Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Drug Delivery Devices. This report contains market size and forecasts of Cell and Gene Therapy Drug Delivery Devices in global, including the following market information:
Global Cell and Gene Therapy Drug Delivery Devices Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cell and Gene Therapy Drug Delivery Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sterile Insulin Syringe Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Drug Delivery Devices include Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute and Kite Pharma, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Cell and Gene Therapy Drug Delivery Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Drug Delivery Devices Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cell and Gene Therapy Drug Delivery Devices Market Segment Percentages, by Type, 2022 (%)
Sterile Insulin Syringe
Pre-Filled Syringe
Infusion Bags
Global Cell and Gene Therapy Drug Delivery Devices Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cell and Gene Therapy Drug Delivery Devices Market Segment Percentages, by Application, 2022 (%)
Luxturna
Kymriah
Provenge
Zolgensma
Yescarta
Strimvelis
Global Cell and Gene Therapy Drug Delivery Devices Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cell and Gene Therapy Drug Delivery Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Drug Delivery Devices revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell and Gene Therapy Drug Delivery Devices revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell and Gene Therapy Drug Delivery Devices, market overview.
Chapter 2: Global Cell and Gene Therapy Drug Delivery Devices market size in revenue.
Chapter 3: Detailed analysis of Cell and Gene Therapy Drug Delivery Devices company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell and Gene Therapy Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cell and Gene Therapy Drug Delivery Devices Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell and Gene Therapy Drug Delivery Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Drug Delivery Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Drug Delivery Devices Overall Market Size
2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size: 2022 VS 2030
2.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell and Gene Therapy Drug Delivery Devices Players in Global Market
3.2 Top Global Cell and Gene Therapy Drug Delivery Devices Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Drug Delivery Devices Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Drug Delivery Devices Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell and Gene Therapy Drug Delivery Devices Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Drug Delivery Devices Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell and Gene Therapy Drug Delivery Devices Market Size Markets, 2022 & 2030
4.1.2 Sterile Insulin Syringe
4.1.3 Pre-Filled Syringe
4.1.4 Infusion Bags
4.2 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2023
4.2.2 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2024-2030
4.2.3 By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Drug Delivery Devices Market Size, 2022 & 2030
5.1.2 Luxturna
5.1.3 Kymriah
5.1.4 Provenge
5.1.5 Zolgensma
5.1.6 Yescarta
5.1.7 Strimvelis
5.2 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2023
5.2.2 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2024-2030
5.2.3 By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell and Gene Therapy Drug Delivery Devices Market Size, 2022 & 2030
6.2 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2023
6.2.2 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2024-2030
6.2.3 By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2030
6.3.2 US Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.3.3 Canada Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.3.4 Mexico Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2030
6.4.2 Germany Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.4.3 France Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.4.4 U.K. Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.4.5 Italy Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.4.6 Russia Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.4.7 Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.4.8 Benelux Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2030
6.5.2 China Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.5.3 Japan Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.5.4 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.5.5 Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.5.6 India Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2030
6.6.2 Brazil Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.6.3 Argentina Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2030
6.7.2 Turkey Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.7.3 Israel Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.7.4 Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
6.7.5 UAE Cell and Gene Therapy Drug Delivery Devices Market Size, 2018-2030
7 Cell and Gene Therapy Drug Delivery Devices Companies Profiles
7.1 Amgen, Inc.
7.1.1 Amgen, Inc. Company Summary
7.1.2 Amgen, Inc. Business Overview
7.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.1.5 Amgen, Inc. Key News & Latest Developments
7.2 Bausch and Lomb Incorporated
7.2.1 Bausch and Lomb Incorporated Company Summary
7.2.2 Bausch and Lomb Incorporated Business Overview
7.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.2.5 Bausch and Lomb Incorporated Key News & Latest Developments
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Company Summary
7.3.2 Becton, Dickinson and Company Business Overview
7.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.3.5 Becton, Dickinson and Company Key News & Latest Developments
7.4 Bluebird bio, Inc.
7.4.1 Bluebird bio, Inc. Company Summary
7.4.2 Bluebird bio, Inc. Business Overview
7.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.4.5 Bluebird bio, Inc. Key News & Latest Developments
7.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
7.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Summary
7.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
7.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Key News & Latest Developments
7.6 Dendreon Pharmaceuticals LLC.
7.6.1 Dendreon Pharmaceuticals LLC. Company Summary
7.6.2 Dendreon Pharmaceuticals LLC. Business Overview
7.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.6.5 Dendreon Pharmaceuticals LLC. Key News & Latest Developments
7.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
7.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Summary
7.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
7.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Key News & Latest Developments
7.8 Human Stem Cell Institute
7.8.1 Human Stem Cell Institute Company Summary
7.8.2 Human Stem Cell Institute Business Overview
7.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.8.5 Human Stem Cell Institute Key News & Latest Developments
7.9 Kite Pharma, Inc.
7.9.1 Kite Pharma, Inc. Company Summary
7.9.2 Kite Pharma, Inc. Business Overview
7.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.9.5 Kite Pharma, Inc. Key News & Latest Developments
7.10 Kolon Tissue Gene, inc.
7.10.1 Kolon Tissue Gene, inc. Company Summary
7.10.2 Kolon Tissue Gene, inc. Business Overview
7.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.10.5 Kolon Tissue Gene, inc. Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Business Overview
7.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Orchard Therapeutics plc.
7.12.1 Orchard Therapeutics plc. Company Summary
7.12.2 Orchard Therapeutics plc. Business Overview
7.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.12.5 Orchard Therapeutics plc. Key News & Latest Developments
7.13 Pfizer, Inc.
7.13.1 Pfizer, Inc. Company Summary
7.13.2 Pfizer, Inc. Business Overview
7.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.13.5 Pfizer, Inc. Key News & Latest Developments
7.14 Renova Therapeutics
7.14.1 Renova Therapeutics Company Summary
7.14.2 Renova Therapeutics Business Overview
7.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.14.5 Renova Therapeutics Key News & Latest Developments
7.15 Spark Therapeutics, Inc.
7.15.1 Spark Therapeutics, Inc. Company Summary
7.15.2 Spark Therapeutics, Inc. Business Overview
7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.15.5 Spark Therapeutics, Inc. Key News & Latest Developments
7.16 uniQure N.V.
7.16.1 uniQure N.V. Company Summary
7.16.2 uniQure N.V. Business Overview
7.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.16.5 uniQure N.V. Key News & Latest Developments
7.17 Vericel Corporation
7.17.1 Vericel Corporation Company Summary
7.17.2 Vericel Corporation Business Overview
7.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Major Product Offerings
7.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue in Global Market (2018-2023)
7.17.5 Vericel Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell and Gene Therapy Drug Delivery Devices Market Opportunities & Trends in Global Market
Table 2. Cell and Gene Therapy Drug Delivery Devices Market Drivers in Global Market
Table 3. Cell and Gene Therapy Drug Delivery Devices Market Restraints in Global Market
Table 4. Key Players of Cell and Gene Therapy Drug Delivery Devices in Global Market
Table 5. Top Cell and Gene Therapy Drug Delivery Devices Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell and Gene Therapy Drug Delivery Devices Product Type
Table 9. List of Global Tier 1 Cell and Gene Therapy Drug Delivery Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Drug Delivery Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell and Gene Therapy Drug Delivery Devices Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2024-2030
Table 30. Amgen, Inc. Company Summary
Table 31. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 32. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen, Inc. Key News & Latest Developments
Table 34. Bausch and Lomb Incorporated Company Summary
Table 35. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 36. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 37. Bausch and Lomb Incorporated Key News & Latest Developments
Table 38. Becton, Dickinson and Company Company Summary
Table 39. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 40. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 41. Becton, Dickinson and Company Key News & Latest Developments
Table 42. Bluebird bio, Inc. Company Summary
Table 43. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 44. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 45. Bluebird bio, Inc. Key News & Latest Developments
Table 46. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Summary
Table 47. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 48. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 49. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Key News & Latest Developments
Table 50. Dendreon Pharmaceuticals LLC. Company Summary
Table 51. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 52. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 53. Dendreon Pharmaceuticals LLC. Key News & Latest Developments
Table 54. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Summary
Table 55. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 56. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 57. Helixmith Co., Ltd (ViroMed Co., Ltd) Key News & Latest Developments
Table 58. Human Stem Cell Institute Company Summary
Table 59. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 60. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 61. Human Stem Cell Institute Key News & Latest Developments
Table 62. Kite Pharma, Inc. Company Summary
Table 63. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 64. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 65. Kite Pharma, Inc. Key News & Latest Developments
Table 66. Kolon Tissue Gene, inc. Company Summary
Table 67. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 68. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 69. Kolon Tissue Gene, inc. Key News & Latest Developments
Table 70. Novartis AG Company Summary
Table 71. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 72. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 73. Novartis AG Key News & Latest Developments
Table 74. Orchard Therapeutics plc. Company Summary
Table 75. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 76. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 77. Orchard Therapeutics plc. Key News & Latest Developments
Table 78. Pfizer, Inc. Company Summary
Table 79. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 80. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 81. Pfizer, Inc. Key News & Latest Developments
Table 82. Renova Therapeutics Company Summary
Table 83. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 84. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 85. Renova Therapeutics Key News & Latest Developments
Table 86. Spark Therapeutics, Inc. Company Summary
Table 87. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 88. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 89. Spark Therapeutics, Inc. Key News & Latest Developments
Table 90. uniQure N.V. Company Summary
Table 91. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 92. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 93. uniQure N.V. Key News & Latest Developments
Table 94. Vericel Corporation Company Summary
Table 95. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Offerings
Table 96. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue (US$, Mn) & (2018-2023)
Table 97. Vericel Corporation Key News & Latest Developments
List of Figures
Figure 1. Cell and Gene Therapy Drug Delivery Devices Segment by Type in 2022
Figure 2. Cell and Gene Therapy Drug Delivery Devices Segment by Application in 2022
Figure 3. Global Cell and Gene Therapy Drug Delivery Devices Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cell and Gene Therapy Drug Delivery Devices Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2022
Figure 8. By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 16. US Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 20. Germany Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 21. France Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 28. China Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 32. India Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 34. Brazil Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue Market Share, 2018-2030
Figure 37. Turkey Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cell and Gene Therapy Drug Delivery Devices Revenue, (US$, Mn), 2018-2030
Figure 41. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
